Topical therapy as monotherapy is useful in psoriasis patients with mild disease. Topical
agents are also used as adjuvant for moderate-to-severe disease who are being …

Topical corticosteroids (TCs) are the pillars of dermatotherapeutics. These drugs are the
“magic molecules,” provided they are used judiciously and appropriately, following a rational …

Psoriasis is a chronic, inflammatory, multisystem disease that affects up to 3.2% of the
United States population. This guideline addresses important clinical questions that arise in …

Planners of interventional studies in psoriasis face the dilemma of selecting suitable quality‐
of‐life (QoL) measures. Systematic reviews have the potential of identifying psychometrically …

Introduction Psoriasis is a common chronic disease with significant impairment in quality of
life. As there is no cure, it often requires lifelong disease control to minimize the …

Survival analysis is concerned with “time to event” data. Conventionally, it dealt with cancer
death as the event in question, but it can handle any event occurring over a time frame, and …

Background Although topical treatments and phototherapy are available for more than 40
years, there is a paucity of evidence‐based recommendations regarding their use …

Background Over 29 years of clinical application, the Dermatology Life Quality Index (DLQI)
has remained the most used patient-reported outcome (PRO) in dermatology due to its …

Background Present investigation was aimed to develop aspasomal gel of Mometasone
Furoate for the treatment of Psoriasis that are biologically active and deliver drug at …

This article is a continuation of the previous module on designing questionnaires and
clinical record form in which we have discussed some basic points about designing the …